This video is sponsored by the Duke Clinical Medical Series.
* Hepatitis C Update from the Major Liver Meetings
* Maintenance Therapy Rationale
* Hepatitis C Update Themes
* R1626 in Combination with PegIFN-alpha 2a RBV: Interim Analysis Results of Phase IIa
* Time- and Dose-dependent Reduction in Viral Load
* Q & A